Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 86 | 100 | 227 | 58 | 58 |
| Accounts receivable | -6 | -9 | -90 | -3 | -36 |
| Other Working Capital | -107 | 15 | -298 | 56 | 230 |
| Other Operating Activity | -455 | -392 | -291 | -301 | -383 |
| Operating Cash Flow | $-482 | $-286 | $-452 | $-190 | $-131 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -2 | -1 | 0 | 0 |
| Purchase Of Investment | 234 | -1,882 | N/A | N/A | N/A |
| Other Investing Activity | 824 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $1,050 | $-1,884 | $-1 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -36 | -104 | -104 | -103 | -103 |
| Common Stock Issued | N/A | N/A | 3,611 | N/A | N/A |
| Other Financing Activity | -22 | 4 | -661 | 347 | 127 |
| Financing Cash Flow | $-58 | $-100 | $2,846 | $244 | $24 |
| Beginning Cash Position | 212 | 2,482 | 89 | 35 | 141 |
| End Cash Position | 722 | 212 | 2,482 | 89 | 35 |
| Net Cash Flow | $510 | $-2,270 | $2,393 | $54 | $-107 |
| Free Cash Flow | |||||
| Operating Cash Flow | -482 | -286 | -452 | -190 | -131 |
| Capital Expenditure | -9 | -2 | -1 | N/A | N/A |
| Free Cash Flow | -491 | -288 | -453 | -190 | -131 |